Atea Pharmaceuticals, Inc. Common Stock
€3.913
EUR
Last updated on --.
24h volume325.17K
24h highest4.0076 EUR
24h lowest3.8442 EUR
24h Price movement+0.44%
AVIR recent prices
24 Hours
+0.44%+€0.0172
30 days
-17.38%-€0.8342
60 days
-9.25%-€0.4042
90 days
-1.50%-€0.0602
Key data
Previous close3.8958 EUR
Market cap288.37M EUR
Volume325.17K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8232 EUR
Net income (FY)-145.78M EUR
Revenue (FY)--
Last report date12 May 2026
About Atea Pharmaceuticals, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)55.00
Net income per employee (FY)-2.65M EUR
Listed onNasdaq
AVIR conversion tables
 |  |
|---|---|
| 0.5 AVIR | 1.956 EUR |
| 1 AVIR | 3.913 EUR |
| 5 AVIR | 19.56 EUR |
| 10 AVIR | 39.13 EUR |
| |
|---|---|
| 0.5 EUR | 0.12778 AVIR |
| 1 EUR | 0.25556 AVIR |
| 5 EUR | 1.277 AVIR |
| 10 EUR | 2.555 AVIR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AVIR is trading at €3.913, +0.44% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AVIR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AVIR is currently trading at €3.913, +0.44% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AVIR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AVIR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AVIR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AVIR's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Atea Pharmaceuticals, Inc. Common Stock's market cap is currently 288.37M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume325.17K
24h highest4.0076 EUR
24h lowest3.8442 EUR
24h Price movement+0.44%
Start trade with AVIR Perpetual
Sign up to trade